Treatment Resistant Depression Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Treatment Resistant Depression pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Treatment Resistant Depression, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Childhood Epilepsy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Childhood Epilepsy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Childhood Epilepsy, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

The cervical cancer (CC) market was valued at $607 million in the 8 major markets (8MM) in 2020. The market is projected to grow at a CAGR of more than 22% during the forecast period.

The cervical cancer market report provides an overview of the risk factors, comorbidities, and global and historical trends for cervical cancer in the eight major markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and Urban China). It includes a 10-year epidemiological forecast for diagnosed incident cases of CC. The diagnosed incident cases of CC are further segmented by age (18–29 years, 30–39 years, 40–49 years, 50–59 years, 60–69 years, 70–79 years, and 80 years and older) in these markets.

C-C chemokine receptor type 4 (CCR4) is expressed on Th2 T lymphocytes and is up-regulated by T cell receptor activation. This receptor also plays an important role in the trafficking of dendritic cells.

The CCR4 pipeline market research report provides comprehensive information on the CCR4 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, the latest news as well as press releases. Additionally, the report provides an overview of key players involved in C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) targeted therapeutics development with respective active and dormant or discontinued projects.

Biohaven’s Nurtec.com achieved the highest traffic across branded migraine patient sites in the US from July 2021 to June 2022, followed by Eli Lilly’s Emgality.com and Allergan’s Botoxchronicmigraine.com. The highest proportion of traffic to these sites originated from direct sources, followed by referrals and organic traffic. Websites for several brands, including Emgality, Vyepti, Botox, and Nurtec, had similar levels of high direct traffic, while Amgen’s Aimovig.com had the lowest.

For patient branded sites, Lundbeck spent the most on digital display advertising (DDA) for Vyepti.com, followed by Allergan’s Botoxchronicmigraine.com. Nurtec.com was supported by the most paid keywords by a large margin, followed by Aimovig.com.

Sanofi/Regeneron’s Dupixent.com achieved the highest traffic across branded severe asthma patient sites in the US from July 2021 to June 2022, followed by Novartis’ Xolair.com, and GSK’s Nucala.com. The highest proportion of traffic to these sites originated from direct sources, followed by organic searches. Amgen/AstraZeneca’s Tezspire.com had the highest amount of direct traffic, while the remaining brands, Dupixent, Cinqair, Nucala, and Xolair, had lower levels of traffic.

For patient branded sites, Sanofi/Regeneron spent the most on digital display advertising (DDA) for Dupixent.com, followed by GSK’s Nucala.com. Dupixent.com was supported by the most paid keywords, followed by Tezspire.com.

Neuromyelitis Optica (NMO), also known as Devic’s disease, is an autoimmune condition that means a person’s immune system reacts abnormally and attacks tissues and organs in the body.

The Neuromyelitis Optica pipeline drugs market research report provides an overview of the Neuromyelitis Optica (Devic’s Syndrome) (Central Nervous System) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Neuromyelitis Optica (Devic’s Syndrome) (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Neuromyelitis Optica (Devic’s Syndrome) (Central Nervous System) and features dormant and discontinued projects.

The Marburgvirus Infections pipeline market report provides a comprehensive overview on the therapeutics under development for Marburgvirus Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Marburgvirus Infections and features dormant and discontinued projects.

Key Targets in the Marburgvirus Infections Pipeline Drugs Market In the Marburgvirus Infections pipeline drugs market the key targets are Ebola virus Matrix Protein VP40, 70 kDa Ribosomal Protein S6 Kinase, Cathepsin L1, Glycoprotein, Hepatitis A Virus Cellular Receptor 1, Interferon Alpha, Interferon Beta, Interferon Gamma, Mannosyl Oligosaccharide Glucosidase, and Marburg Virus Membrane Associated Protein VP24.

Kidney transplantation is a therapy performed to replace a diseased kidney with a healthy kidney from another person. Risk factors associated with transplantation are bleeding, infection, blockage of the blood vessels to the new kidney, leakage of urine or blockage of urine in the ureter, and initial lack of function of the new kidney. Its treatment includes immunosuppressive drugs that aid in preventing organ rejection.

The Kidney Transplant Rejection pipeline market research report provides comprehensive information on the therapeutics under development for Kidney Transplant Rejection, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Kidney Transplant Rejection and features dormant and discontinued projects.

Gamma-aminobutyric acid A receptor, alpha 2 or GABRA2 are activated by the major inhibitory neurotransmitter in the mammalian brain and has been found to mediate anxiolytic activity, which plays a key role in emotional and behavioral control.

The Gamma-Aminobutyric Acid Receptor Subunit Alpha 2 (GABA(A) Receptor Subunit Alpha 2 or GABRA2) pipeline drugs market research report outlays comprehensive information on the Gamma-Aminobutyric Acid Receptor Subunit Alpha 2 (GABA(A) Receptor Subunit Alpha 2 or GABRA2) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews key players involved in Gamma-Aminobutyric Acid Receptor Subunit Alpha 2 (GABA(A) Receptor Subunit Alpha 2 or GABRA2) targeted therapeutics development with respective active and dormant or discontinued projects.

Immuno-oncology is one of the fastest growing segments in oncology, with over 60 therapies across five drug classes, either approved or in pre-registration as of January 2022. The development of immune checkpoint inhibitors and CAR-T therapies in a variety of oncology indications has matured and is particularly robust across the US and China.​

Genomics and gene editing technologies, such as CRISPR, have allowed the development of new game-changing treatments. These include gene therapies, oncolytic viruses, oligonucleotides, DNA vaccines, mRNA vaccines, and recombinant vector vaccines. ​While long-touted for their potential to address unmet needs in infectious diseases, mRNA vaccines showed little advancement through clinical development. However, the arrival of COVID-19 saw the rapid development of highly efficacious mRNA vaccines.

The emerging market for disposable endoscopes is rapidly growing, with new types of disposable endoscopes and manufacturers entering the market every year. Some, like disposable bronchoscopes, have been available on the market for over 10 years, while others, such as disposable duodenoscopes, have only been approved for use since late 2019. Given its emerging nature with high interest among healthcare professionals seeking to minimize cross-contamination of their reusable endoscopes, the initial few years of this market growth have experienced double-digit and even triple-digit growth. Currently, this market is being dominated by just a few manufacturers, however as this market matures over time, large, diversified medical device manufacturers are expected to enter this market and increase its competitiveness.

The diabetic foot ulcers market size was valued at US$ 4.74 billion in 2021 and is expected to grow at a CAGR of 7.1% during 2022-2027. The key to the diabetic foot ulcers market growth has been the rising prevalence of diabetes and resulting increase in incidence of diabetic foot ulcers. Additionally, rise in geriatric population, and increasing adoption of novel biologics and wound care devices for treatment are the key market drivers.

NPWT Devices and Accessories Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030 is built to visualize quantitative market trends within Wound Care Management therapeutic area.

The model discusses in detail the impact of COVID-19 on NPWT Devices and Accessories market for the year 2020 and beyond. While alternative clinical uses for NPWT are currently being explored, the technique is most notably indicated for patients suffering from acute or chronic wounds. Wounds that do not heal in a predictable amount of time, or that are non-healing, are considered to be chronic, while acute wounds are those that heal at more predictable rates. Although stand-alone NPWT devices and their accessories make up the largest segment of the market, disposable NPWT devices have significantly risen in popularity since their introduction to the market and are experiencing high growth rates globally.

Glaucoma surgery devices are used to augment normal physiologic aqueous outflow pathways to provide effective intra-ocular pressure. Glaucoma surgery devices are designed to divert aqueous humor from the anterior chamber to an external reservoir, where a fibrous capsule forms about 4-6 weeks after surgery and regulates flow.

The glaucoma surgery devices market research report provides comprehensive information about the glaucoma surgery devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Moreover, the glaucoma surgery devices report provides information about various pipeline products and their estimated approval dates.

Aesthetic injectables refer to gel-like substances that are injected beneath the skin to restore a more youthful appearance. GlobalData's Medical Devices sector report, “Aesthetic Injectables Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" provides comprehensive information about the Aesthetic Injectables pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Aesthetic Injectables report provides key information and data related to: Extensive coverage of the Aesthetic Injectables under development Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates Reviews of major players involved in the pipeline product development. Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and the number of trials of the major Aesthetic Injectables pipeline products.

Radiation Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Radiation Injury pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Radiation Injury, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.